Bulk Orders 20+ bottles
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Neurocognitive Research
NSI-189 is a capsule research product. It contains 20MG per capsule in bottles of 60 capsules per bottle, with 1,200MG total NSI-189 content. It is made for controlled laboratory investigations of neurogenic pathways and hippocampal pathway models.
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkPublished product documentation
A certificate is not currently available for this product. Published reports remain available below; check the lot before using a report.
Verified test results
Each batch is analyzed by Freedom Diagnostics, an independent third-party laboratory, before release. Below is the report for lot NI01, summarized from the certificate the lab published.
This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.
Side by side
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Encapsulated research material
NSI-189 is a capsule research product. It contains 20MG per capsule in bottles of 60 capsules per bottle, with 1,200MG total NSI-189 content. It is made for controlled laboratory investigations of neurogenic pathways and hippocampal pathway models. Studies also cover neuroplasticity signaling, cognitive pathways, and neurochemical response systems. Other research examines CNS adaptation models and neural resilience pathways.
Disguised Alpha NSI-189 comes as a finished capsule product. It is for researchers who need clear 20MG strength labels and clean capsule presentation. They also need professional manufacturing standards, internal QA review, and direct in-house fulfillment.
| Compound | NSI-189 |
|---|---|
| Strength | 20MG per capsule |
| Count | 60 capsules |
| Total Content | 1,200MG |
| Format | finished capsule research product |
Advanced CNS Pathway Research
NSI-189 is studied in controlled models of neurogenic signaling and hippocampal pathways. Other models examine neuroplasticity-associated systems, CNS response behavior, and cognitive pathways. These studies use structured laboratory conditions.
Studied in models of neurogenic signaling and neural pathway response. Models also cover cellular adaptation and CNS-related pathway behavior.
Relevant to laboratory investigations of hippocampal pathways and neuroplasticity models. Studies also cover cognitive pathways and neural resilience systems.
A finished 60-count capsule format with clear 20MG strength labeling. Each bottle has 1,200MG total NSI-189 content.
NSI-189 is studied in models of neurogenic pathways and hippocampal signaling. Other models cover neuroplasticity-associated biology, cognitive pathways, and CNS adaptation systems.
Research examines how CNS-active compounds may affect neural pathways and hippocampal response models. It also studies neurochemical signaling, neural resilience systems, and cognitive pathways. These studies use controlled laboratory conditions.
The 20MG 60 capsule format is clearly labeled and supplied finished. It has 1,200MG total NSI-189 for structured laboratory handling and records.
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
It is the stated quantity per unit, separate from the number of units in the bottle. A purity percentage is not a measurement of milligrams per capsule or tablet. Use the matching lot report for the measurements actually performed.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
A small synthetic molecule, not a peptide: (4-benzylpiperazin-1-yl)-[2-(3-methylbutylamino)pyridin-3-yl]methanone, C₂₂H₃₀N₄O at 366.5 g/mol as the free base (PubChem). Neuralstem developed it and studied it as a neurogenic compound, and its international nonproprietary name is amdiglurax. Trials have used its phosphate salt, NSI-189 phosphate, which Alto Neuroscience later tested as ALTO-100.
Yes, as research history, as NSI-189 phosphate in major depressive disorder: a randomized, double-blind, placebo-controlled phase 1b study with three ascending cohorts in 24 inpatients over 28 days assessed pharmacokinetics and exploratory rating scales, and a double-blind, placebo-controlled phase 2 trial randomized 220 outpatients for 12 weeks, with the Montgomery-Asberg Depression Rating Scale (MADRS) as its primary outcome measure.
Not in a direct test. A 2019 mouse study co-authored by Neuralstem staff associated NSI-189's effects on hippocampal synaptic plasticity with TrkB and Akt pathway activation, but in a 2021 screen of compounds published as TrkB activators, NSI-189 showed no binding to the TrkB extracellular domain, no TrkB phosphorylation and no positive allosteric modulation of BDNF at TrkB.
This page sells NSI-189 as capsules: 20MG per capsule in bottles of 60 capsules per bottle, with 1,200MG total NSI-189 content, and its lot's certificate of analysis, from Freedom Diagnostics, is shown on the page. It is sold exclusively for laboratory research purposes, not for human, veterinary, or food use, and ships from the US West Coast, by FedEx 2-Day shipping.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy